CORPUS CHRISTI, Texas--(BUSINESS WIRE)--The CryoPen has changed the way that cryosurgery is done and the medical community is embracing the change. This month CryoPen celebrated the shipment of its 1000th unit.
“Doctors are excited to incorporate the CryoPen into their practices,” says Dr. Mike Haas, inventor of the CryoPen. “General practitioners, OB/GYNs and podiatrists have all successfully brought the CryoPen into their offices. It helps them offer a wider range of services to their clients and helps add another revenue stream to their practices.”
The Cryopen is the most innovative device for the delivery of cryo-therapy treatments without the need for dangerous cryogeneic liquids and gases that are typically used today. The Cryopen is used to treat a wide range of lesions including warts, actinic keratoses, seborrheic keratoses, condylomas and skin tags.
“What sets the CryoPen apart from other cryosurgery techniques is the fact that it’s simple, safe and effective for doctors and their trained staff members to use,” says David Moxam, Chairman, CryoPen.
The CryoPen delivers treatment at -105° Celsius temperature and patients typically require only one treatment. This is a much less complicated approach than dangerous cryogenic liquids and gases, like liquid nitrogen, that were used in the past. The CryoPen also delivers results without leaving scars or burning the patient’s surrounding tissue.
If you're interested in seeing a demonstration of The CryoPen, please visit http://www.cryopen.com.
CryoPen, LLC is a leading cryosurgical innovator; designing, developing, marketing and selling its CryoPen Surgical System to primary care physicians, family practice physicians, general practice physicians, obstetrics and gynecologists, pediatricians, internists and dermatologists. For more information, please visit http://www.cryopen.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6613353&lang=en